Public Profile

Teva Puerto Rico LLC

Teva Puerto Rico LLC, a subsidiary of Teva Pharmaceutical Industries Ltd., is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 1996, the company has significantly contributed to the healthcare sector, particularly in the production of generic and specialty medications. With major operations in Puerto Rico, Teva Puerto Rico focuses on manufacturing high-quality pharmaceuticals that cater to diverse therapeutic areas, including pain management, respiratory health, and central nervous system disorders. Teva Puerto Rico is renowned for its commitment to innovation and quality, offering a wide range of products that meet stringent regulatory standards. The company has achieved notable milestones, including expanding its manufacturing capabilities and enhancing its product portfolio. As a leader in the generic drug market, Teva Puerto Rico continues to play a vital role in improving patient access to essential medications while maintaining a strong market position in the pharmaceutical landscape.

DitchCarbon Score

How does Teva Puerto Rico LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Teva Puerto Rico LLC's score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Teva Puerto Rico LLC's reported carbon emissions

Teva Puerto Rico LLC, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess the company's climate impact or its strategies for addressing carbon emissions. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, but specific actions or targets from Teva Puerto Rico LLC remain unspecified.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Teva Puerto Rico LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Teva Puerto Rico LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Teva Puerto Rico LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aptalis Holdings Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Ferring Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers